Linking a pharmaceutical claims database with a birth defects registry to investigate birth defect rates of suspected teratogens

Authors:

Colvin L, Slack-Smith L, Stanley FJ, Bower C

Authors notes:

Pharmacoepidemiology Drug Safety 2010 Nov;19(11):1137-50

Keywords:

pharmaceutical claims database, birth defects registry, investigate birth defect rates, suspected teratogenss

Abstract

Data linkage of population administrative data is being investigated as a tool for pharmacovigilance in pregnancy in Australia. Records of prescriptions of known or suspected teratogens dispensed to pregnant women have been linked to a birth defects registry to determine if defects associated with medicine exposure can be detected